It once filled the gap in the domestic market for MRI diagnostics and ranks at the Top 3 in the segment market.
It’s has been sold for nearly 20 years old and has served almost 10 million patients.
It has the national patent of production technology and is of same quality with European and American products. It broke the monopoly position of multinational enterprises in the Chinese contrast agent market.
Indications:MRI for human internal organs and cells, such as nervous centralis (brain and spinal cord), stomach, chest, pelvic cavity and extremities; Also used for renal function assessment.

It’s used for neuroradiology, angiography, urography, and can enhance scanning, arthrography, sacral angiography and digital subtraction angiography effects during the CT examination.

Its application for registration will be submitted soon and it is expected to be launched in 2021. Based on the microbubble research, micro-bubble drug delivery can be used for precise targeted therapy to achieve "diagnosis and treatment integration" in the future and create a new era of diagnostic medicine and therapeutic development.